This NRC develops and provides special and clinically relevant microbiological tests and resources for CF research and therapeutics development, including clinical specimens and microbial isolates, uncommon culture media and conditions, and molecular (DNA-based) microbiological identification and quantitation. This core will also serve as a repository of the specimens and isolates collected by CF studies; as a facility that can perform existing, nonstandard tests (such as sputum binding and in vitro susceptibility testing for new candidate treatments); and as a laboratory that develops new approaches and resources and performs new tests, such as DNA-based analyses.
Site: University of Washington, Seattle
Director:
Lucas Hoffman, MD, PhD
lhoffm@uw.edu
Other personnel:
Donna Prybell, Core Administrator
dprybell@uw.edu
Stephen Salipante, MD, PhD, Sequencing Subcore Director
stevesal@uw.edu
Rafael Hernandez, MD, PhD, Clinical Isolate Subcore Director
rafael.hernandez@seattlechildrens.org